Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/24/2025

Cardioversion and Conversion Pauses in Atrial Fibrillation

Introduction to Conversion Pauses

  • The American College of Cardiology, American Heart Association, and European Society of Cardiology guidelines do not recommend permanent pacemaker implantation for isolated conversion pauses from atrial fibrillation, as these pauses are common during cardioversion and typically do not indicate underlying sinus node or AV nodal dysfunction requiring intervention 1
  • Conversion pauses result from temporary suppression of sinus node activity or transient AV nodal block during the transition from AF to sinus rhythm, and are a well-recognized phenomenon that can occur during both spontaneous and pharmacological cardioversion 2

Evaluation and Management of Conversion Pauses

  • For asymptomatic 7-second conversion pauses, observation without specific intervention is recommended, and no pacemaker implantation is indicated, with a focus on continuing management of the underlying atrial fibrillation 1
  • For symptomatic conversion pauses, short-term cardiac monitoring (24-48 hours) to assess for recurrent pauses is recommended, and if no recurrent significant pauses occur, no specific intervention is needed, but if recurrent symptomatic pauses persist, further evaluation may be warranted 2
  • Patients with structural heart disease may be at higher risk for recurrent significant pauses, and echocardiography may be indicated to assess cardiac structure and function, according to the ACC/AHA/ESC guidelines 1

Medication Considerations

  • Certain medications, such as digoxin, beta-blockers, and calcium channel blockers, can exacerbate conversion pauses by prolonging sinus node recovery time or suppressing sinus node function, and consideration should be given to temporary reduction or discontinuation of these medications prior to planned cardioversion 2

Follow-up and Further Evaluation

  • Routine follow-up to ensure maintenance of sinus rhythm is recommended after successful cardioversion, and if the patient remains in AF, continue appropriate rate control and anticoagulation therapy, with consideration of Holter monitoring if symptoms suggest recurrent significant pauses 1
  • If a patient experiences recurrent symptomatic pauses not limited to the conversion period, further evaluation for sinus node dysfunction may be warranted, and an electrophysiology study may be considered in selected cases with recurrent symptomatic bradycardia 2